Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Felipe Reyes-Cosmelli

1PUBLICATIONS

20CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 17, 2025

KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.

Hope S Rugo, David W Cescon, Mark E Robson

Pageof 1

Frequent Collaborators

1 joint publications

Hope S Rugo

1 joint publications

David W Cescon

1 joint publications

Mark E Robson

1 joint publications

Seock-Ah Im

1 joint publications

Florence Dalenc

1 joint publications

Eduardo Yañez Ruiz

1 joint publications

Janice M Walshe

1 joint publications

Young-Hyuck Im

1 joint publications

Sergii Kulyk

1 joint publications

Oleksandr Dudnichenko

Frequent Collaborators

1 joint publications

Hope S Rugo

1 joint publications

David W Cescon

1 joint publications

Mark E Robson

1 joint publications

Seock-Ah Im

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos